• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性运动障碍

Drug-induced movement disorders.

作者信息

Duma Stephen R, Fung Victor Sc

机构信息

Movement Disorders Unit, Department of Neurology, Westmead Hospital, Sydney.

Sydney Medical School, University of Sydney.

出版信息

Aust Prescr. 2019 Apr;42(2):56-61. doi: 10.18773/austprescr.2019.014. Epub 2019 Apr 1.

DOI:10.18773/austprescr.2019.014
PMID:31048939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6478951/
Abstract

Many therapeutic and illicit drugs can cause movement disorders. Antipsychotics and antiemetics are most commonly implicated The time of onset of the movement disorder may be acute, subacute, or chronic. The severity can range from mild to severe and life-threatening Early recognition of a drug-induced movement disorder is essential to allow for prompt intervention. This includes stopping the offending drug, supportive care, and sometimes other pharmacological treatment

摘要

许多治疗性药物和违禁药物可导致运动障碍。抗精神病药物和止吐药最常与此有关。运动障碍的起病时间可能为急性、亚急性或慢性。严重程度可从轻度到重度甚至危及生命。早期识别药物引起的运动障碍对于及时干预至关重要。这包括停用致病药物、支持性治疗,有时还包括其他药物治疗。

相似文献

1
Drug-induced movement disorders.药物性运动障碍
Aust Prescr. 2019 Apr;42(2):56-61. doi: 10.18773/austprescr.2019.014. Epub 2019 Apr 1.
2
Acute and subacute drug-induced movement disorders.急性和亚急性药物诱导的运动障碍。
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S108-12. doi: 10.1016/S1353-8020(13)70027-0.
3
Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.药物诱导运动障碍的临床特征:97 例患者研究。
Tremor Other Hyperkinet Mov (N Y). 2020 Oct 26;10:48. doi: 10.5334/tohm.554.
4
Long-Term Response to Clozapine and Its Clinical Correlates in the Treatment of Tardive Movement Syndromes: A Naturalistic Observational Study in Patients With Psychotic Disorders.长期氯氮平治疗迟发性运动障碍综合征及其临床相关性的反应:精神障碍患者的自然观察研究。
J Clin Psychopharmacol. 2019 Nov/Dec;39(6):591-596. doi: 10.1097/JCP.0000000000001114.
5
Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.药物性比萨综合征(侧扭痉挛):流行病学与管理
CNS Drugs. 2002;16(3):165-74. doi: 10.2165/00023210-200216030-00003.
6
Neuroleptic malignant syndrome: a review for neurohospitalists.抗精神病药恶性综合征:给神经科住院医师的综述
Neurohospitalist. 2011 Jan;1(1):41-7. doi: 10.1177/1941875210386491.
7
Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.未使用过第一代抗精神病药物的非老年精神分裂症患者使用第二代抗精神病药物后的迟发性运动障碍和迟发性肌张力障碍:一项横断面回顾性研究。
J Clin Psychopharmacol. 2015 Feb;35(1):13-21. doi: 10.1097/JCP.0000000000000250.
8
[Neuroleptic-induced movement disorders: historical perspectives].[抗精神病药物所致运动障碍:历史视角]
Encephale. 1993 Nov-Dec;19(6):657-61.
9
The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.甲氧氯普胺所致迟发性运动障碍和急性锥体外系运动障碍的患病率。
Arch Intern Med. 1993 Jun 28;153(12):1469-75.
10
Tardive syndromes.迟发性综合征。
J Neurol Sci. 2018 Jun 15;389:35-42. doi: 10.1016/j.jns.2018.02.005. Epub 2018 Feb 5.

引用本文的文献

1
Exploring the Role of Oral Microbiota in the Pathophysiology and Treatment of Bruxism.探索口腔微生物群在磨牙症病理生理学及治疗中的作用。
FASEB J. 2025 Sep 15;39(17):e71017. doi: 10.1096/fj.202502015R.
2
Movement disorders associated with diarrhoea.与腹泻相关的运动障碍。
J Neural Transm (Vienna). 2025 Jul 17. doi: 10.1007/s00702-025-02924-0.
3
The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review.非抗精神病药物所致肌张力障碍的流行病学与现象学:一项系统-叙述性混合综述
Eur Psychiatry. 2025 Feb 10;68(1):e36. doi: 10.1192/j.eurpsy.2025.18.
4
Guideline for pharmacological treatment of schizophrenia 2022.《2022年精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12497. doi: 10.1002/npr2.12497. Epub 2024 Nov 25.
5
Overview of Movement Disorders Secondary to Drugs.药物所致运动障碍概述
Clin Pract. 2023 Aug 18;13(4):959-976. doi: 10.3390/clinpract13040087.
6
Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review.单核苷酸多态性作为抗精神病药引起静坐不能的生物标志物:系统评价。
Genes (Basel). 2023 Feb 28;14(3):616. doi: 10.3390/genes14030616.
7
Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey.临床医生对远程医疗服务在药物性运动障碍管理中的负面影响及质量改进机会的看法:一项2021年基于互联网的调查。
Neuropsychiatr Dis Treat. 2022 Dec 19;18:2945-2955. doi: 10.2147/NDT.S385960. eCollection 2022.
8
Repurposable Drugs That Interact with Steroid Responsive Gene Targets for Inner Ear Disease.可再利用药物与内耳疾病的类固醇反应性基因靶点相互作用。
Biomolecules. 2022 Nov 5;12(11):1641. doi: 10.3390/biom12111641.
9
Drug-Induced Hyperthermia Review.药物性高热综述
Cureus. 2022 Jul 26;14(7):e27278. doi: 10.7759/cureus.27278. eCollection 2022 Jul.
10
A Case Report of Baclofen- and Clozapine-Induced Dyskinesia: A Movement Disorder.巴氯芬与氯氮平所致运动障碍:一例病例报告
Cureus. 2022 May 17;14(5):e25068. doi: 10.7759/cureus.25068. eCollection 2022 May.

本文引用的文献

1
The hot patient: acute drug-induced hyperthermia.发热患者:急性药物性高热
Aust Prescr. 2019 Feb;42(1):24-28. doi: 10.18773/austprescr.2019.006. Epub 2019 Feb 1.
2
Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications.甲基苯丙胺使用与帕金森病未来发病风险:证据与临床意义。
Drug Alcohol Depend. 2018 Jun 1;187:134-140. doi: 10.1016/j.drugalcdep.2018.02.032. Epub 2018 Apr 10.
3
Tardive syndromes.迟发性综合征。
J Neurol Sci. 2018 Jun 15;389:35-42. doi: 10.1016/j.jns.2018.02.005. Epub 2018 Feb 5.
4
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.迟发性运动障碍的治疗:概述及重点关注囊泡单胺转运体 2 抑制剂。
Drugs. 2018 Apr;78(5):525-541. doi: 10.1007/s40265-018-0874-x.
5
Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.更新迟发性运动障碍治疗建议:新证据的系统评价和实用治疗算法。
J Neurol Sci. 2018 Jun 15;389:67-75. doi: 10.1016/j.jns.2018.02.010. Epub 2018 Feb 5.
6
The nosology of tardive syndromes.迟发性综合征的分类学。
J Neurol Sci. 2018 Jun 15;389:10-16. doi: 10.1016/j.jns.2018.02.008. Epub 2018 Feb 6.
7
Deep brain stimulation for tardive syndromes: Systematic review and meta-analysis.深部脑刺激治疗迟发性运动障碍的系统评价和荟萃分析。
J Neurol Sci. 2018 Jun 15;389:55-60. doi: 10.1016/j.jns.2018.02.013. Epub 2018 Feb 5.
8
An update on new and unique uses of botulinum toxin in movement disorders.肉毒杆菌毒素在运动障碍中的新独特用途的最新进展。
Toxicon. 2018 Jun 1;147:84-88. doi: 10.1016/j.toxicon.2017.09.003. Epub 2017 Sep 6.
9
Medication-Induced Tardive Dyskinesia: A Review and Update.药物性迟发性运动障碍:综述与更新
Ochsner J. 2017 Summer;17(2):162-174.
10
Common toxidromes in movement disorder neurology.
Postgrad Med J. 2017 Jun;93(1100):326-332. doi: 10.1136/postgradmedj-2016-134254. Epub 2016 Oct 7.